| 1 |
32541643 | Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial. | 2020 Jun 16 |
1 |
| 2 |
32923098 | C-reactive protein reduction with sacubitril-valsartan treatment in heart failure patients. | 2020 |
3 |
| 3 |
23148500 | The comparative effects of valsartan and amlodipine on vascular microinflammation in newly diagnosed hypertensive patients. | 2013 |
2 |
| 4 |
20664555 | Angiotensin II receptor blockade with valsartan decreases plasma osteopontin levels in patients with essential hypertension. | 2011 May |
2 |
| 5 |
19911855 | Valsartan: more than a decade of experience. | 2009 |
1 |
| 6 |
17923463 | Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial. | 2008 Mar |
1 |
| 7 |
16939632 | C-reactive protein (CRP)-lowering agents. | 2006 Spring |
1 |
| 8 |
16129801 | C-reactive protein in heart failure: prognostic value and the effect of valsartan. | 2005 Sep 6 |
4 |
| 9 |
15172423 | Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy. | 2004 Jun 2 |
2 |